WC
REGN icon

Woodstock Corp’s Regeneron Pharmaceuticals REGN Stock Holding History

Woodstock Corp’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Buy
20,518
+663
+3% +$451K 1.06% 29
2026
Q1 		$15.3M Buy
19,855
+1,209
+6% +$926K 1.37% 19
2025
Q4 		$14.4M Buy
18,646
+2,036
+12% +$1.38M 1.24% 22
2025
Q3 		$9.34M Buy
16,610
+8,589
+107% +$4.86M 0.81% 38
2025
Q2 		$4.21M Buy
8,021
+906
+13% +$506K 0.39% 64
2025
Q1 		$4.51M Buy
7,115
+2,460
+53% +$1.69M 0.45% 62
2024
Q4 		$3.32M Sell
4,655
-505
-10% -$424K 0.32% 70
2024
Q3 		$5.42M Buy
5,160
+541
+12% +$602K 0.52% 56
2024
Q2 		$4.85M Buy
4,619
+397
+9% +$385K 0.49% 57
2024
Q1 		$4.06M Buy
4,222
+170
+4% +$162K 0.42% 66
2023
Q4 		$3.56M Buy
4,052
+137
+3% +$113K 0.41% 66
2023
Q3 		$3.22M Buy
3,915
+938
+32% +$737K 0.4% 66
2023
Q2 		$2.14M Buy
2,977
+259
+10% +$200K 0.25% 77
2023
Q1 		$2.23M Buy
2,718
+47
+2% +$35.4K 0.28% 74
2022
Q4 		$1.93M Sell
2,671
-31
-1% -$22.9K 0.26% 76
2022
Q3 		$1.86M Buy
2,702
+242
+10% +$152K 0.28% 74
2022
Q2 		$1.45M Buy
2,460
+23
+0.9% +$14.9K 0.2% 82
2022
Q1 		$1.7M Buy
2,437
+125
+5% +$79.1K 0.2% 84
2021
Q4 		$1.46M Buy
2,312
+199
+9% +$122K 0.15% 91
2021
Q3 		$1.28M Buy
2,113
+1,044
+98% +$648K 0.15% 92
2021
Q2 		$597K Buy
1,069
+436
+69% +$221K 0.07% 131
2021
Q1 		$299K Buy
+633
New +$308K 0.04% 162

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Woodstock Corp's REGN Position: Q2 2026 in Review

Woodstock Corp increased its Regeneron Pharmaceuticals (REGN) stake by 3.3% in Q2 2026, buying an estimated $451K and bringing the position to 20,518 shares worth $12.8M. The position accounts for 1.06% of the portfolio, ranked #29.

Woodstock Corp first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $15.3M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Woodstock Corp held 20,518 shares of Regeneron Pharmaceuticals worth $12.8M as of Q2 2026.
  • Woodstock Corp bought 663 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $451K.
  • Regeneron Pharmaceuticals made up 1.06% of Woodstock Corp's portfolio in Q2 2026, its #29 holding.
  • Woodstock Corp first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Woodstock Corp's Regeneron Pharmaceuticals position peaked at $15.3M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Woodstock Corp's 13F filing for Q2 2026, filed 13 Jul 2026.